At a glance
- Originator Aventis
- Class Analgesics; Local anaesthetics; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 25 Sep 1995 New profile
- 25 Sep 1995 Discontinued - preclinical development in Pain in France (Unknown route)